FONAR Corp (FONR)
NASDAQHealth CareMedical - Equipment & ServicesSnapshot 2026-09-04
$19.090.00%
Close 2026-06-05 · 1-day change
NASDAQHealth CareMedical - Equipment & ServicesSnapshot 2026-09-04
Warn: Primary pillar under pressure — Manage new MRI center in Nassau County by end of Fiscal 2026: Merger closed 2026-06-03; delisting requested; entity no longer independent.
FONAR is expanding by managing a new MRI center in Nassau County this fiscal year. The company completed a merger that changes control and delists it from Nasdaq. It secured a $20 million credit facility to support operations. These moves could stabilize and grow the business.
The merger and delisting bring uncertainty and management turnover. The new credit agreement adds debt risk. Growth is slow with only about 1.5% revenue increase expected. These factors may pressure the company’s recovery.
The stock trades about 45% below our valuation range. The market expects roughly 1.5% revenue growth, reflecting cautious sentiment. Our view sees potential from the merger and new MRI center but acknowledges risks from recent changes.
Breaks if: Merger not completed or delisting reversed after June 3, 2026
FONAR Corp completed a merger, resulting in changes in control and delisting from Nasdaq.
Breaks if: New MRI center is not operational by end of FY26
FONAR Corp plans to manage an entirely new MRI center in Nassau County before the end of Fiscal 2026.
Breaks if: Credit agreement terminated or materially restricted before FY27
FONAR Corp entered into a new credit agreement with OceanFirst Bank, N.A., providing a $20 million term loan facility.
Breaks if: Revenue growth falls below 1.5% YoY
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a cyclical play within the healthcare sector. The current thesis state is cautious, as recent financial performance has been strong, but there are concerns about execution and sector volatility.
The market currently prices FONR as cheap compared to its peers, reflecting a low expectations gap. This suggests that investors are aware of the company's weak execution quality and the turbulent sector environment.
Fundamentals may remain strong in the near term, but management execution is mixed, particularly regarding acquisition activities and credit agreements. The recent rise in company quality is a positive sign, but risks remain elevated.
The long-term thesis hinges on management's ability to navigate upcoming challenges, including potential guidance cuts and the impact of a weakening jobs report. Additionally, positive momentum from sector leaders like MMED could provide support.
Overall, FONR's performance will depend on management execution and external economic factors. Not investment advice.
The most important moves since the prior daily snapshot.
Our read on the company is unchanged since the prior snapshot.
as of 2026-09-04
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.